Regístrese
¿Aún no está registrado?
Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta
Buscar en
Porto Biomedical Journal
Toda la web
Inicio Porto Biomedical Journal Prediction of cardiovascular risk in preterm neonates through urinary proteomics...
Journal Information
Vol. 2. Num. 6.November - December 2017
Pages 247-346
Share
Share
Download PDF
More article options
Visits
1476
Vol. 2. Num. 6.November - December 2017
Pages 247-346
Original article
DOI: 10.1016/j.pbj.2017.04.002
Open Access
Prediction of cardiovascular risk in preterm neonates through urinary proteomics: An exploratory study
Visits
1476
Estela Cabrala, Henrique Soaresb, Hercília Guimarãesb,c, Rui Vitorinoc,e,
Corresponding author
rvitorino@ua.pt

Corresponding author at: Department of Medical Sciences, Universidade de Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal.
, Rita Ferreirad, Tiago Henriques-Coelhob,c
a School of Health Sciences, University of Minho, Braga, Portugal
b Departmento de Pediatria, Faculdade de Medicina, Universidade do Porto, Porto, Portugal
c Departamento de Cirurgia e Fisiologia, Faculdade de Medicina, Universidade do Porto, Porto, Portugal
d QOPNA, Department of Chemistry, University of Aveiro, Aveiro, Portugal
e iBiMED, Department of Medical Sciences, University of Aveiro, Aveiro, Portugal
Highlights

  • Urine proteomics allows the identification of the pathways modulated in neonates.

  • Up-regulated pathways in preterm include immunity, metabolism and oxidative stress.

  • Some of these pathways seem to be modulated by the nutritional support.

  • AGT and RBP4 might be related to the development of cardiovascular diseases.

This item has received
1476
Visits

Under a Creative Commons license
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (6)
Show moreShow less
Abstract

Preterm birth has been associated with an increased risk of cardiovascular diseases (CVD) in adulthood. The goal of our study was to give new molecular insights on the relationship between prematurity and CVD risk and to identify putative biomarkers that would facilitate the development of effective screening and therapeutic strategies. In this sense, mass spectrometry (MS)-based proteomics was applied to the characterization of urine protein profile.

GeLC–MS/MS analysis of urine (desalted and concentrated with a 10-kDa filter) followed by bioinformatics was applied for the characterization of preterm and full-term neonates. Urine proteome profiling retrieved 434 unique proteins, from which 126 were common to both groups, 37 were unique to preterm and 58 to full-term neonates. Protein-protein interaction analysis for unique proteins and common ones present in significant distinct levels retrieved immune system, metabolism, defense systems and tissue remodeling as the most representative clusters in preterm neonates.

Metabolic adaptation along with the up-regulation of heart growth (identified by angiotensinogen and retinol-binding protein 4) may account for an increased CVD risk in preterm neonates. These proteins may have predictive value of CVD in adulthood of this specific group of neonates. The follow-up of urinary proteome dynamics of preterm and full-term neonates will be crucial for the validation of this hypothesis.

Keywords:
Cardiovascular diseases
GeLC–MS/MS
Low birth weight
Neonates
Urine
Abbreviations:
AGT
CVD
GeLC
MS
RBP4
Full Text
Introduction

Low birth weight is the leading cause of morbidity and mortality in the neonatal period and in childhood overall. Over recent decades both the incidence of preterm birth and survival rates of preterm infants has increased, with babies born as early as 25 weeks gestation now having near 80% chance to survive. Due to the immaturity of the organs at the time of birth, preterm infants exhibit an increased risk of developing a number of postnatal complications, namely cardiovascular and kidney diseases.1

Cardiovascular diseases (CVD) are the leading cause of mortality in developed countries, with over 4 million deaths each year.2 For many years it was thought that the cardiovascular condition was determined solely by genetic factors and lifestyle, which includes amount of physical activity and quality of nutrition.3 In 1989, Barker et al.4 established a direct correlation between low birth weight and CVD in adulthood. This included hypertension and cardiovascular mortality. In the last decades, this discovery was confirmed and deeply explored with research being conducted on both animals and humans. The data collected suggests that the complex interaction between genetic constitution and the prenatal and early postnatal environment determines the growth and development of the fetus and defines the susceptibility to certain disorders in adult life, like hypertension, diabetes, dyslipidemia and coagulation disorders.5,6 Other studies have shown a relationship between preterm birth and cardiovascular diseases, namely, increased risk of cerebrovascular disease in young adulthood,7 elevated blood pressure8 in adolescent girls and an atherogenic lipid profile in boys,9 metabolic syndrome in later life, increased plasma low-density lipoprotein,10 altered lipid and apolipoprotein metabolism with increased atherogenic indices at birth,11 increased risk of atrial fibrillation,12 and later-life risk of type 2 diabetes.13

The development of proteomic techniques based on mass spectrometry has prompted the search for novel protein markers for many diseases. Proteomics allow a high-throughput analysis of samples as biofluids with the identification and quantification of thousands of proteins and peptides modulated by a given pathophysiological condition that might be seen as potential biomarkers.14 Urine is one of the most interesting and useful biofluids for routine testing and provides an excellent resource for the identification of novel biomarkers, with the advantage over blood samples due to the ease and less invasive nature of collection.15 Urine proteomics have been used to identify biomarkers associated with several diseases in neonates, such as broncopulmonary dysplasia16 and necrotizing enterocolitis.17 For the time being, no specific urine biomarkers have been identified that may correlate with the increased risk of CVD in preterm infants.

The goal of the present study was to better understand the biological mechanisms by which prematurity is associated with increased risk for CVD, and identify potential biomarkers that would facilitate the development of effective screening and therapeutic strategies.

MethodsCharacterization of the study population

Eight neonates followed by the neonatology service of Hospital São João – Porto were enrolled in the present study. The protocol was approved by the local ethics committee and the parents of all participating neonates gave their informed consent.

Neonates from the PreTerm group (n=4) presented at birth a body weight of 1.23±0.14kg whereas all neonates from the Term group (n=4) showed a body weight higher than 3.00kg. Mean gestational age in the PreTerm group was 29±1 weeks. All neonates of the Term group had a gestational age ≥37 weeks. Female and male neonates were included in both groups. Neonates from PreTerm group were given multivitamin and iron supplements. PreTerm neonates were also under parenteral nutrition, were submitted to phototherapy for jaundice, and received antibiotics for infectious risk. These neonates represent the typical clinical profile of PreTerm infants.

Sample collection and urine examination

Urine was collected in the first 20 days after birth by a non-invasive approach using sterile bags. Urine samples (approximately 10mL) were then submitted to centrifugation for 2min at 4000× g at 4°C. In order to concentrate samples and remove salts, the supernatant was passed through 10-kDa filters (Vivaspin 500-10kDa, Sartorius Biotech). The retentate was ressuspended in 100μL of a solution of 6M urea, 2M tiourea, 1% CHAPS and 0.5% SDS. Total protein content was estimated using the RC-DC assay kit (BioRad®).

SDS-PAGE and in-gel digestion

Protein samples (40μg) were separated by SDS-PAGE, using 12.5% polyacrylamide gels prepared as previously described.18 Gels were stained with BlueSafe® solution and were scanned with Gel Doc XR System (Bio-Rad). Samples were analyzed in duplicate. Following SDS-PAGE, complete lanes were cut out of the gel and sliced into 16 sections. Each section was in-gel digested with trypsin (0.01μg/μL trypsin prepared in ammonium hydrogenocarbonate). Digestion process was quenched by the addition of 10% formic acid. Peptides were extracted from gel fragments by the addition of a solution of 10% formic acid and ultrapure acetonitrile (ACN; 1:1) and dried on a SpeedVac.

nanoLC–MS/MS analysis and protein ID

The dried extracted peptides were dissolved in 10μL of mobile phase A (0.1% trifluoroacetic acid (TFA), 5% ACN, 95% water). All peptide mixtures were analyzed in two separate times. The tryptic digests were then separated using an Ultimate 3000 (Dionex, Sunnyvale, CA) onto a 150mm×75μm Pepmap100 C18 column with 3μm particle size (Dionex, LC Packings) at a flow rate of 300nL/min. The gradient started at 10min and ramped to 50% Buffer B (85% ACN, 0.04% TFA) over a period of 45min. The chromatographic separation was monitored at 214nm using a UV detector (Dionex/LC Packings) equipped with a 3nL flow cell. The peptides eluting from the column were mixed with a continuous flow of matrix solution (270nL/min, 2mg/mL α-Cyano-4-hydroxycinnamic acid in 70% ACN/0.3% TFA and internal standard Glu-Fib at 15fmol) in a fraction microcollector (Probot, Dionex/LC Packings) and directly deposited onto the LC-MALDI plates at 20s intervals for each spot.

Samples were analyzed using a 4800 MALDI-TOF/TOF Analyzer (AbSCIEX). A S/N threshold of 50 was used to select peaks for MS/MS analyses. The spectra were processed using the TS2Mascot (v1.0, Matrix Science Ltd.) and submitted to Mascot software (v.2.1.0.4, Matrix Science Ltd.) for peptide/protein identification. Searches were performed in MASCOT using Homo sapiens release 13102014. Search was performed including data from all slices for global protein identification and emPAI calculation. A MS tolerance of 30ppm was found for precursor ions and 0.3Da for fragment ions, as well as two missed cleavages and methionine oxidation as variable modification. The confidence levels accepted for positive protein identification were p<0.05. A false positive rate below 5% was obtained using a random database. Furthermore, proteins identified with one peptide were manually validated when MS/MS spectra presented at least 4 successive amino acids covered by b or y fragmentations.

Protein quantification and abundance measurement

The abundance of identified proteins was estimated by calculating the emPAI.19 The emPAI is an exponential form of PAI−1 (the number of detected peptides divided by the number of observable peptides per protein, normalized by the theoretical number of peptides expected via in silico digestion) defined as emPAI=10PAI1 and the corresponding protein content in mole percent is calculated as mol %=(emPAI/ΣPemPAI)×100. Microsoft Office Excel was used to calculate the mole percent. The theoretically observable peptides were determined by the in silico digestion of mature proteins using the output of the program Protein Digestion Simulator (http://panomics.pnnl.gov/software/). The observed peptides were unique parent ions including those with 2 missed cleavage. Mean protein emPAI values were log2 transformed for protein ratio calculation.

A CSV (comma separated values) dataset containing relevant information pertaining to all identified proteins was analyzed to extract meaningful information. An in-house developed C# program using Language Integrated Query (Microsoft Visual Studio 2012; Microsoft, USA) was used for data-mining the dataset. The output of the program has given several statistics which were then used by R Language scripts to produce emPAI distribution facilitating the dataset analysis.

Results

In order to characterize the urinary proteome profile, proteins from desalted urine samples were separated according to their molecular weight by SDS-PAGE. The large-scale LC–MS/MS analysis of all gel bands retrieved 434 unique proteins (Supplemental Table S1). According to PANTHER software,20 most of these proteins belong to the biological processes “metabolism”, “cellular processes” and “developmental processes”. Binding, catalytic activity and structural molecular activity are the most significant molecular functions of the identified proteins. Regarding cellular component, 30% of the identified proteins have extracellular origin.

In order to evaluate the effect of low birth weight on urinary protein profile, a label free quantification of GeLC–MS/MS data was performed. No differences were noticed in gel bands’ profile among groups (Supplemental Figure S1). From the 236 proteins identified in the urine of at least two neonates, 126 were common to PreTerm and Term groups (Fig. 1), including, for instance, albumin, uromodulin and osteopontin. The analysis with PANTHER software demonstrated that most of the 58 proteins only identified in the urine of the Term group are related to catalytic and binding activities, structural molecular activity and receptor activity. Regarding the PreTerm group, most of the 37 unique proteins are involved in binding and catalytic activities, being receptor and enzyme regulator activities other important molecular functions.

Fig. 1.
(0.06MB).

Venn diagram representing the distribution of identified peptides per group evidencing the overlapped and unique peptides.

Protein-protein interaction analysis with ClueGo and CluePedia, considering unique proteins identified in the PreTerm and Term groups was performed (Supplemental Figure S2). “Immune response”, “negative regulation of vasculature development” and “lipid storage and metabolism” are the most representative clusters in the PreTerm group. “Carbohydrate catabolic process”, “peptide metabolic process”, “forebrain neuron development” and “extracellular matrix organization” are the most representative clusters in the Term group.

Comparative abundance analysis evidenced alpha-1-antitrypsin, beta-2-microglobulin, retinol-binding protein 4, plasma protease C1 inhibitor, antithrombin-III and angiotensinogen as the most abundant proteins in the PreTerm group and cubilin, glutathione S-transferase P, calbindin, Ig kappa chain V and alpha-1-acid glycoprotein 1 as the most abundant ones in Term group (Fig. 2).

Fig. 2.
(0.35MB).

Normalized abundance of urinary proteins in PreTerm vs. Term groups. Protein accession number has correspondence to protein name at Supplemental Table S1.

Protein–protein interaction analysis with ClueGo and CluePedia was performed, considering common proteins present in significant distinct levels (based on emPAI values) in the Term and PreTerm groups (Supplemental Figure S3). Major clusters of interacting proteins include those involved in “complement activation”, “blood coagulation”, “negative regulation of endopeptidase activity”, “retinol binding” and “heart growth”, which were up-regulated in PreTerm neonates. The clusters “negative regulation of apoptosis in response to DNA damage”, “regulation of chemokine production” and “kidney morphogenesis” were found down-regulated in this group of neonates.

Protein-protein interaction analysis performed with ClueGo and CluePedia considering unique proteins, and the ones in significant distinct levels highlights the up-regulation of “immune response” and “inflammation” in preterm neonates (Fig. 3).

Fig. 3.
(0.31MB).

ClueGo and CluePedia analysis of protein-protein interaction considering unique proteins per group and common proteins present in significant distinct levels (based on emPAI values) in the urine of neonates from Term and PreTerm groups. Green nodes refer to biological processes positively regulated in preterm neonates whereas red nodes refer to the ones widespread in term neonates. As can be depicted, immune response, negative regulation of endopeptidase activity, regulation of defense response, ion homeostasis and catabolic processes are biological processes prevalent in preterm neonates.

Discussion

Our study highlights the impact of low birth weight-related clinical profile on urinary proteome, allowing a better understanding of the molecular pathways modulated by it, envisioning the identification of potential CVD biomarkers with diagnosis and prognosis significance.

Despite the low number of neonates enrolled in this exploratory study, data analysis highlight some biological processes modulated by prematurity, which validation with other methodologies in a higher cohort of neonates should be considered in the future. Metabolism was one of the biological processes altered in preterm neonates. Indeed, in PreTerm group lipid metabolism seems to prevail with proteins such as fatty acid-binding protein (FABP1), ribonuclease pancreatic (RNASE1), protein complement C3 and beta-hexosaminidase subunit beta (HEXB). It is known that newborn have minimum energy requirements for basal metabolism and growth that influence energy expenditure. Both energy and protein are necessary for a normal growth, and carbohydrates are the main source of energy for the brain and heart. Several weeks after birth, lipid oxidation develops. Most preterm newborns have greater needs of energy in order to approximate normal intrauterine growth and energy is mainly obtained from lipid metabolism.21 However, preterm infants have immature lipoprotein lipase activity (secondary to limited adipose tissue mass), which puts them at greater risk for hypertriglyceridemia.22 This metabolic adaptation observed might be a consequence of the nutritional support usually given at Neonate Intensive Care Unit in the early days of life for the necessary “catch-up” growth. However, rapid gains in adiposity have the potential to produce later life obesity, an increasingly recognized risk of excessive energy intake.21

Upon birth, infants are exposed to relatively high concentrations of oxygen (O2) compared with intrauterine life. Under physiological conditions, blood oxygen saturation levels (SpO2) of the fetus average 45% to 55%.23 In the first few minutes after birth, blood oxygen content and O2 availability abruptly increase,24 which may alter oxygen-sensing pathways in the preterm neonates.25 The exposure to higher circulating oxygen concentrations elicits a burst of reactive oxygen species,26 which might be potentiated by iron supplementation. This usual therapeutic choice improves indicators of hematologic iron status and reduces the occurrence of iron-deficiency anemia in low birth weight infants; however, its effect on growth and neurodevelopment remains elusive.27 Some authors argue that the administration of ferrous iron might induce oxidative stress through the Fenton reaction, which might overload the immature antioxidant system of preterm neonates.28 Oxidative damage due to reactive oxygen species (ROS) generation has been linked to DNA damage and lipid peroxidation in premature newborns29 as well with the development of preterm associated diseases30 and adult diseases, including cardiovascular disease, cancer, chronic inflammation, and neurologic disorders.31

Inflammation is intimately associated with increased oxidative stress which is present in preterm birth. Previous studies have shown increased inflammation markers in both mother and newborn, including those born preterm.32 Oxidative stress and low-grade inflammation all contribute to the pathogenesis of chronic disorders, such as hypertension, cardiovascular and kidney diseases, and type 2 diabetes mellitus.25 In the preterm group, we observed an increase in lymphocyte mediated immunity, characterized by the unique proteins lysosome-associated membrane glycoprotein 1 (LAMP1) and C3, up-regulation of beta-2-microglobulin (B2MG) and hemopexin (HPX), and of proteins involved in complement activation (plasma protease C1 inhibitor (SERPING1) and mannan-binding lectin serine protease 2 (MASP2)). The activation of this pathway reflects the fact that preterm neonates are not fully immunocompetent at birth33 being more susceptible to infection than term neonates.34

Altered cardiac growth, negative regulation of vasculature development, suppressed contractile function and enhanced responsiveness to stress are among the alterations reported in preterm neonates. These effects might contribute to the increased vulnerability of organ perfusion in preterm neonates.35 Indeed, a cluster that stands out in the PreTerm group is that involved in heart growth and cardiac muscle tissue growth. During maturation of the heart, fetal cardiomyocytes undergo both hyperplasia and hypertrophy. In humans, cardiomyocytes proliferate actively until 36-week gestation after which maturation, differentiation, and growth by hypertrophy take place.36 Angiotensinogen (AGT) and retinol-binding protein 4 (RBP4) were found up-regulated in the PreTerm group, that are involved in heart growth. Increased levels of these proteins were already related to increased risk of cardiovascular disease.37 AGT is an essential component of the renin-angiotensin system, a potent regulator of blood pressure, body fluid and electrolyte homeostasis.38 Polymorphisms of AGT have been associated to an increased risk of heart diseases in newborns.39

Although hypertension would not be caused by changes in cardiac structure and function after preterm birth per se, the heart of preterm-born neonates may be particularly susceptible to the effect of elevated blood pressure and associated risk factors for heart disease.39 The up-regulation of S100A9 further supports preterm-related increased risk of cardiovascular diseases, once was suggested to be an early marker for the detection of acute coronary syndromes40 and of cardiovascular risk in humans.40

Taken together, in the present study we have provided new insights on the molecular pathways up-regulated in preterm neonates using urine proteomics, namely lymphocyte mediated immunity, metabolism adaptation, oxidative stress, negative regulation of vasculature development and tissue remodeling. These pathways are related with cardiac development, supported by the presence of cardiac growth-related proteins in the PreTerm group, AGT and RBP4. Since immune response, oxidative stress and metabolic adaptation are intimately related with the development of cardiovascular diseases, the unique and upregulated proteins found in the PreTerm group may be seen as putative biomarkers to be included in multimarker strategies for the identification of neonates that are at higher risk of developing cardiovascular diseases. Future studies in a large cohort of preterm and term neonates as well as the follow-up of urinary proteome dynamics will be important to test the diagnosis value of these proteins.

Conflicts of interest

The authors declare no conflicts of interest.

Acknowledgments

This work was supported by Portuguese Foundation for Science and Technology (FCT), European Union, QREN, FEDER and COMPETE for funding the UnIC, iBiMED and QOPNA research units (UID/IC/00051/2013, UID/BIM/04501/2013 and UID/QUI/00062/2013), RV (IF/00286/2015), and by RNEM (Portuguese Mass Spectrometry Network).

The authors thank to nurses’ team from Neonate Intensive Care Unit of Hospital São João for their support in collecting newborns’ urine samples.

Appendix A
Supplementary data

The following are the supplementary data to this article:

(0.09MB).
(0.12MB).
(0.23MB).

References
[1]
P. Kutz, S. Horsch, L. Kuhn, C. Roll
Single-centre vs. population-based outcome data of extremely preterm infants at the limits of viability
Acta Paediatrica, 98 (2009), pp. 1451-1455 http://dx.doi.org/10.1111/j.1651-2227.2009.01393.x
[2]
Nichols M, Townsend N, Luengo-Fernandez R, Leal J, Gray A, Scarborough P, M R. European Cardiovascular Disease Statistics 2012. Brussels, European Society of Cardiology, Sophia Antipolis: European Heart Network; 2012.
[[3]]
G.S. Berenson
Childhood risk factors predict adult risk associated with subclinical cardiovascular disease. The Bogalusa Heart Study
Am J Cardiol, 90 (2002), pp. 3L-7L
[4]
D.J. Barker, C. Osmond, J. Golding, D. Kuh, M.E. Wadsworth
Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease
BMJ, 298 (1989), pp. 564-567
[5]
P.D. Gluckman, M.A. Hanson
Developmental origins of disease paradigm: a mechanistic and evolutionary perspective
[6]
E. Demicheva, F. Crispi
Long-term follow-up of intrauterine growth restriction: cardiovascular disorders
Fetal Diagnosis Therapy, 36 (2014), pp. 143-153 http://dx.doi.org/10.1159/000353633
[7]
P. Ueda, S. Cnattingius, O. Stephansson, E. Ingelsson, J.F. Ludvigsson, A.K. Bonamy
Cerebrovascular and ischemic heart disease in young adults born preterm: a population-based Swedish cohort study
Eur J Epidemiol, 29 (2014), pp. 253-260 http://dx.doi.org/10.1007/s10654-014-9892-5
[8]
M.O. Edwards, W.J. Watkins, S.J. Kotecha, J.P. Halcox, F.D. Dunstan, A.J. Henderson
Higher systolic blood pressure with normal vascular function measurements in preterm-born children
Acta Paediatrica, 103 (2014), pp. 904-912 http://dx.doi.org/10.1111/apa.12699
[9]
M. Sipola-Leppanen, M. Vaarasmaki, M. Tikanmaki, P. Hovi, S. Miettola, A. Ruokonen
Cardiovascular risk factors in adolescents born preterm
Pediatrics, 134 (2014), pp. e1072-e1081 http://dx.doi.org/10.1542/peds.2013-4186
[10]
J.R. Parkinson, M.J. Hyde, C. Gale, S. Santhakumaran, N. Modi
Preterm birth and the metabolic syndrome in adult life: a systematic review and meta-analysis
Pediatrics, 131 (2013), pp. e1240-e1263 http://dx.doi.org/10.1542/peds.2012-2177
[11]
H. Shoji, Y. Murano, M. Mori, N. Matsunaga, N. Ohkawa, H. Suganuma
Lipid profile and atherogenic indices soon after birth in Japanese preterm infants
Acta Paediatrica, 103 (2014), pp. 22-26 http://dx.doi.org/10.1111/apa.12436
[12]
S.O. Lawani, E.W. Demerath, F.L. Lopez, E.Z. Soliman, R.R. Huxley, K.M. Rose
Birth weight and the risk of atrial fibrillation in whites and African Americans: the Atherosclerosis Risk In Communities (ARIC) study
BMC Cardiovasc Disord, 14 (2014), pp. 69 http://dx.doi.org/10.1186/1471-2261-14-69
[13]
T. Harder, E. Rodekamp, K. Schellong, J.W. Dudenhausen, A. Plagemann
Birth weight and subsequent risk of type 2 diabetes: a meta-analysis
Am J Epidemiol, 165 (2007), pp. 849-857 http://dx.doi.org/10.1093/aje/kwk071
[14]
K.P. Law, T.L. Han, C. Tong, P.N. Baker
Mass spectrometry-based proteomics for pre-eclampsia and preterm birth
Int J Mol Sci, 16 (2015), pp. 10952-10985 http://dx.doi.org/10.3390/ijms160510952
[15]
H. Mischak, W. Kolch, M. Aivaliotis, D. Bouyssié, M. Court, H. Dihazi
Comprehensive human urine standards for comparability and standardization in clinical proteome analysis
Proteomics - Clin Appl, 4 (2010), pp. 464-478 http://dx.doi.org/10.1002/prca.200900189
[16]
A. Bhandari, V. Bhandari
Biomarkers in bronchopulmonary dysplasia
Paediatr Respir Rev, 14 (2013), pp. 173-179 http://dx.doi.org/10.1016/j.prrv.2013.02.008
[[17]]
K.G. Sylvester, X.B. Ling, G.Y. Liu, Z.J. Kastenberg, J. Ji, Z. Hu
Urine protein biomarkers for the diagnosis and prognosis of necrotizing enterocolitis in infants
J Pediatr, 164 (2014), pp. 607-612 http://dx.doi.org/10.1016/j.jpeds.2013.10.091
e601-607
[18]
U.K. Laemmli
Cleavage of structural proteins during the assembly of the head of bacteriophage T4
Nature, 227 (1970), pp. 680-685
[19]
Y. Ishihama, Y. Oda, T. Tabata, T. Sato, T. Nagasu, J. Rappsilber
Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein
Mol Cell Proteomics: MCP, 4 (2005), pp. 1265-1272 http://dx.doi.org/10.1074/mcp.M500061-MCP200
[20]
P.D. Thomas, M.J. Campbell, A. Kejariwal, H. Mi, B. Karlak, R. Daverman
PANTHER: a library of protein families and subfamilies indexed by function
Genome Res, 13 (2003), pp. 2129-2141 http://dx.doi.org/10.1101/gr.772403
[21]
W.W. Hay Jr., L.D. Brown, S.C. Denne
Energy requirements, protein-energy metabolism and balance, and carbohydrates in preterm infants
World Rev Nutr Diet, 110 (2014), pp. 64-81 http://dx.doi.org/10.1159/000358459
[22]
M.S. Lim, C.W. Choi, B.I. Kim, H.R. Yang
Clinical factors affecting lipid metabolism and optimal dose of heparin in preterm infants on parenteral nutrition
Pediatr Gastroenterol Hepatol Nutr, 16 (2013), pp. 116-122 http://dx.doi.org/10.5223/pghn.2013.16.2.116
[23]
N. Finer, O. Saugstad, M. Vento, K. Barrington, P. Davis, S. Duara
Use of oxygen for resuscitation of the extremely low birth weight infant
Pediatrics, 125 (2010), pp. 389-391 http://dx.doi.org/10.1542/peds.2009-1247
[24]
C.O. Kamlin, C.P. O’Donnell, P.G. Davis, C.J. Morley
Oxygen saturation in healthy infants immediately after birth
[25]
M.R. Sutherland, M. Bertagnolli, M.A. Lukaszewski, F. Huyard, C. Yzydorczyk, T.M. Luu
Preterm birth and hypertension risk: the oxidative stress paradigm
[26]
M. Comporti, C. Signorini, S. Leoncini, G. Buonocore, V. Rossi, Ciccoli L. Plasma
F2-isoprostanes are elevated in newborns and inversely correlated to gestational age
Free Radical Biol Med, 37 (2004), pp. 724-732
[27]
H. Long, J.M. Yi, P.L. Hu, Z.B. Li, W.Y. Qiu, F. Wang
Benefits of iron supplementation for low birth weight infants: a systematic review
[28]
G.D. Georgeson, B.J. Szony, K. Streitman, I.S. Varga, A. Kovacs, L. Kovacs
Antioxidant enzyme activities are decreased in preterm infants and in neonates born via caesarean section
Eur J Obstetr Gynecol Reprod Biol, 103 (2002), pp. 136-139
[29]
R. Negi, D. Pande, A. Kumar, R.S. Khanna, H.D. Khanna
In vivo oxidative DNA damage and lipid peroxidation as a biomarker of oxidative stress in preterm low-birthweight infants
J Trop Pediatr, 58 (2012), pp. 326-328 http://dx.doi.org/10.1093/tropej/fmr078
[30]
C. Dani, A. Cecchi, G. Bertini
Role of oxidative stress as physiopathologic factor in the preterm infant
Minerva Pediatr, 56 (2004), pp. 381-394
[31]
R. Menon
Oxidative stress damage as a detrimental factor in preterm birth pathology
Front Immunol, 5 (2014), pp. 567 http://dx.doi.org/10.3389/fimmu.2014.00567
[32]
Z.H. Aghai, J. Camacho, J.G. Saslow, K. Mody, R. Eydelman, V. Bhat
Impact of histological chorioamnionitis on tracheal aspirate cytokines in premature infants
Am J Perinatol, 29 (2012), pp. 567-572 http://dx.doi.org/10.1055/s-0032-1311980
[33]
E. Juretic, A. Juretic, B. Uzarevic, M. Petrovecki
Alterations in lymphocyte phenotype of infected preterm newborns
Biol Neonate, 80 (2001), pp. 223-227 http://dx.doi.org/10.1159/000047147
[34]
T. Moodley, C. Vella, O. Djahanbakhch, C.J. Branford-White, Crawford M.A. Arachidonic
docosahexaenoic acid deficits in preterm neonatal mononuclear cell membranes. Implications for the immune response at birth
Nutr Health, 20 (2009), pp. 167-185 http://dx.doi.org/10.1177/026010600902000206
[35]
M. Tare, J.G. Bensley, T.J. Moss, B.E. Lingwood, M.Y. Kim, S.K. Barton
Exposure to intrauterine inflammation leads to impaired function and altered structure in the preterm heart of fetal sheep
Clin Sci, 127 (2014), pp. 559-569 http://dx.doi.org/10.1042/CS20140097
[36]
M. Mollova, K. Bersell, S. Walsh, J. Savla, L.T. Das, S.Y. Park
Cardiomyocyte proliferation contributes to heart growth in young humans
Proc Natl Acad Sci U S A, 110 (2013), pp. 1446-1451 http://dx.doi.org/10.1073/pnas.1214608110
[37]
Q. Sun, U.A. Kiernan, L. Shi, D.A. Phillips, B.B. Kahn, F.B. Hu
Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: a prospective analysis among women in the nurses’ health study
Circulation, 127 (2013), pp. 1938-1947 http://dx.doi.org/10.1161/CIRCULATIONAHA.113.002073
[[38]]
C. UniProt
Activities at the Universal Protein Resource (UniProt)
Nucl Acids Res, 42 (2014), pp. D191-D198 http://dx.doi.org/10.1093/nar/gkt1140
[39]
I. Goracy, G. Dawid, B. Loniewska, J. Goracy, A. Ciechanowicz
Genetics of the renin-angiotensin system with respect to cardiac and blood pressure phenotypes in healthy newborn infants
J Renin-angiotensin-aldosterone Syst, 14 (2013), pp. 337-347 http://dx.doi.org/10.1177/1470320312450531
[40]
L.A. Altwegg, M. Neidhart, M. Hersberger, S. Muller, F.R. Eberli, R. Corti
Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes
Eur Heart J, 28 (2007), pp. 941-948 http://dx.doi.org/10.1093/eurheartj/ehm078
Copyright © 2017. PBJ-Associação Porto Biomedical/Porto Biomedical Society
es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos